Skip to main content
Fig. 4 | Trials

Fig. 4

From: A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards

Fig. 4

Non-inferiority margin implications of expanding the BALANCE main RCT to include non-ICU ward patients, as a function of the final percentage of patients enrolled from non-ICU wards and fixing the sample size at 3626. The point estimates (solid black line) assume a mortality rate of 17.3% among ICU patients and 12.8% in non-ICU ward patients, with 95% certainty estimates around those estimates (gray shaded area)

Back to article page